Role of adenosine receptors in volatile anesthetic preconditioning against neutrophil-induced contractile dysfunction in isolated rat hearts

Anesthesiology

Volumn 103, Issue 2, 2005, Pages 287-295

  Hu, Guochang ^a,b   Salem, M Ramez ^a,b   Crystal, George J ^a,b  

^a ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 PHENYLTHEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; INHALATION ANESTHETIC AGENT; ISOFLURANE; MYELOPEROXIDASE; SEVOFLURANE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HEART LEFT VENTRICLE; HEART VENTRICLE CONTRACTILITY; INHALATION ANESTHESIA; ISOLATED HEART; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY;

EID: 23044500396     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200508000-00012     Document Type: Article

References (50)

1. ATP channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87:361-70
2. Cope DK, Impastato WK, Cohen MV, Downey JM: Volatile anesthetics protect the ischemic rabbit myocardium from infarction. ANESTHESIOLOGY 1997; 86:699-709
3. Cason BA, Gamperl AK, Slocum RE, Hickey RF: Anesthetic-induced preconditioning: Previous administration of isoflurane decreases myocardial infarct size in rabbits. ANESTHESIOLOGY 1997; 87:1182-90
4. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Is isoflurane-induced preconditioning dose related? ANESTHESIOLOGY 2002; 96:675-805.
5. Ismaeil MS, Tkachenko I, Gamperl AK, Hickey RF, Cason BA: Mechanisms of isoflurane-induced myocardial preconditioning in rabbits. ANESTHESIOLOGY 1999; 90:812-21
6. Belhomme D, Peynet J, Loouzy M, Launay J-M, Kitakaze M, Menasché P: Evidence for preconditioning by isoflurane in coronary artery bypass surgery. Circulation 1999; 100 (suppl 11):340-4
7. Hanouz JL, Yvon A, Massetti M, Lepage O, Babatasi G, Khayat A, Bricard H, Gérard JL: Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. ANESTHESIOLOGY 2002; 97:33-41
8. Tanaka K, Ludwig LM, Kersten JR, Pagel PS. Warltier DC: Mechanisms of cardioprotection by volatile anesthetics. ANESTHESIOLOGY 2004; 100:707-21
9. I receptors and adenosine triphosphate-sensitive potassium channels. ANESTHESIOLOGY 2000; 92:1692-701
10. Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, Warltier DC: Sarcolemmal and mitochondrial adenosine triphosphate- dependent potassium channels: Mechanism of desflurane-induced cardioprotection. ANESTHESIOLOGY 2000; 92:1731-9
11. Piriou V, Chiari P, Knezynski S, Bastien O, Loufoua J, Lehot JJ, Foëx P, Annat G, Ovize M: Prevention of isoflurane-induced preconditioning by 5-hydroxydecanoate and gadolinium: Possible involvement of mitochondrial adenosine triphosphate-sensitive potassium and stretch-activated channels. ANESTHESIOLOGY 2000; 93:756-64
12. Heindl B, Reichle FM, Zahler S, Conzen PF, Becker BF: Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. ANESTHESIOLOGY 1999; 91:521-30
13. Hu G, Vasiliauskas T, Salem MR, Rhone DP, Crystal GJ: Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. ANESTHESIOLOGY 2003; 98:712-8
14. Hu G, Salem MR, Crystal GJ: Isoflurane and sevoflurane precondition against neutrophil-induced contractile dysfunction in isolated rat hearts. ANESTHESIOLOGY 2004; 100:489-97
15. Hu G, Vinten-Johansen J, Salem MR, Zhao Z-Q, Crystal GJ: Isoflurane inhibits neutrophil-endothelium interaction in the coronary circulation: Lack of role for adenosine triphosphate-sensitive potassium channels. Anesth Analg 2002; 94:849-56
16. Johnson ME, Sill JC, Uhl CB, Halsey TJ, Gores GJ: Effect of volatile anesthetics on hydrogen peroxide-induced injury in aortic and pulmonary arterial endothelial cells. ANESTHESIOLOGY 1996; 84:103-16
17. Tanguay M, Blaise G, Dumont L, Beique G, Hollmann C: Beneficial effects of volatile anesthetics on decrease in coronary flow and myocardial contractility induced by oxygen-derived free radicals in isolated rabbit hearts. J Cardiovasc Pharmacol 1991; 18:863-70
18. de Klaver MJ, Manning L, Palmer LA, Rich GF: Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells. ANESTHESIOLOGY 2002; 97:24-32
19. Plachinta RV, Hayes JK, Cerilli LA, Rich GF: Isoflurane pretreatment inhibits lipopolysaccharide-induced inflammation in rats. ANESTHESIOLOGY 2003; 98:89-95
20. Headrick JP, Hack B, Ashton KJ: Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol 2003; 285:H1797-818
21. Vinten-Johansen J, Thourani VH, Ronson RS, Jordan JE, Zhao ZQ, Nakamura M, Velez D, Guyton RA: Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 1999; 68:1942-8
22. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC: Role of adenosine in isoflurane-induced cardioprotection. ANESTHESIOLOGY 1997; 86:1128-39
23. Semb AG, Ytrehus K, Vaage J, Myklebust R, MjØs OD: Functional impairment in isolated rat hearts induced by activated leukocytes: Protective effect of oxygen free radical scavengers. J Mol Cell Cardiol 1989; 21:877-87
24. Angello DA, Headrick JP, Coddington NM, Berne RM: Adenosine antagonism decreases metabolic but not functional recovery from ischemia. Am J Physiol 1991; 260:H193-200
25. Askenasy N, Navon G: Intermittent ischemia: Energy metabolism, cellular volume regulation, adenosine and insights into preconditioning. J Mol Cell Cardiol 1997; 29:1715-30
26. Kamekura I, Okumura K, Matsui H, Murase K, Mokuno S, Toki Y, Nakashima Y, Ito T: Mechanisms of hypoxic coronary vasodilatation in isolated perfused rat hearts. J Cardiovasc Pharmacol 1999; 33:836-42
27. Nakamura M, Thourani VH, Ronson RS, Velez DA, Ma XL, Katzmark S, Robinson J, Schmarkey LS, Zhao ZQ, Wang NP, Guyton RA, Vinten-Johansen J: Glutathione reverses endothelial damage from peroxynitrite, the byproduct of nitric oxide degradation, in crystalloid cardioplegia. Circulation 2000; 102: III332-8
28. Lefer DJ, Flynn DM, Phillips ML, Ratcliffe M, Buda AJ: A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation 1994; 90:2390-401
29. Habre W, Petak F, Sly PD, Hantos Z, Morel DR: Protective effects of volatile agents against methacholine-induced bronchoconstriction in rats. ANESTHESIOLOGY 2001; 94:348-53
30. Koblin DD, Eger EI II, Johnson BH, Collins P, Harper MH, Terrell RC, Speers L: Minimum alveolar concentrations and oil/gas partition coefficients of four anesthetic isomers. ANESTHESIOLOGY 1981; 54:314-7
31. Kazama T, Ikeda K: Comparison of MAC and the rate of rise of alveolar concentration of sevoflurane with halothane and Isoflurane in the dog. ANESTHESIOLOGY 1988; 68:435-7
32. Halsey MJ: Potency and physical properties of inhalational anesthetics, General Anesthesia, 5th edition. Edited by Nunn JE, Utting JE, Brown BR. London, Butterworths, 1989, pp 7-18
33. Zar JH: Chapter 10: Paired-sample hypotheses, Biostatistical Analysis. Edited by McElroy WD, Swanson CP. Englewood Cliffs, New Jersey, Prentice-Hall, 1974, pp 121-4
34. Zar JH: Chapter 12: Multiple comparisons, Biostatistical Analysis. Edited by McElroy WD, Swanson CP, Englewood Cliffs, New Jersey, Prentice-Hall, 1974, pp 151-62
35. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am J Physiol 1996; 271:H1456-64
36. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther 1997; 280:301-9
37. 3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am J Physiol 1999; 277:H1895-905
38. 2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J Biol Chem 1996; 271:17114-8
39. Ding J, Badwey JA: Stimulation of neutrophils with a chemoattractant activates several novel protein kinases that can catalyze the phosphorylation of peptides derived from the 47-kDa protein component of the phagocyte oxidase and myristoylated alanine-rich C kinase substrate. J Biol Chem 1993; 268:17326-33
40. Ding J, Badwey JA: Effects of antagonists of protein phosphatases on Superoxide release by neutrophils. J Biol Chem 1992; 267:6442-8
41. Lu DJ, Takai A, Leto TL, Grinstein S: Modulation of neutrophil activation by okadaic acid, a protein phosphatase inhibitor. Am J Physiol 1992; 262:C39-49
42. Burkey TH, Webster RO: Adenosine inhibits fMLP-stimulated adherence and superoxide anion generation by human neutrophils at an early step in signal transduction. Biochim Biophys Acta 1993; 1175:312-8
43. Theron AJ, Steel HC, Tintinger GR, Anderson R: Endogenous adenosine regulates neutrophil pro-inflammatory activities by cyclic AMP-dependent accelerated clearance of cytosolic calcium. Inflamm Res 2002; 51:594-602
44. Thelen M, Dewald B, Baggiolini M: Neutrophil signal transduction and activation of the respiratory burst. Physiol Rev 1993; 73:797-821
45. Möbert J, Zahler S, Becker BF, Conzen PF: Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. ANESTHESIOLOGY 1999; 90:1372-81
46. Wollner A, Wollner S, Smith JB: Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (Cd11b/CD18) expression on FMLP-stimulated neutrophils. Am J Respir Cell Mol Biol 1993; 9:179-85
47. ATP-channel activation. Am J Physiol 1997; 273:H1677-87
48. ATP channel. Am J Physiol 1994; 266:H829-39
49. 2 receptors and cAMP-dependent protein kinase. Proc Natl Acad Sci U S A 1995; 92:12441-5
50. I) receptor in isolated rat heart. Br J Anaesth 2001; 87:258-65